drag_handle
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Enhancing Gut Health Visualization and Companion Support: Launching Gut Testing Kits in Japan
AuB Inc. (Headquarters: Chuo-ku, Tokyo; President: Keita Suzuki; hereinafter “AuB”), which develops and sells products and services for improving physical condition, has entered into a business partnership agreement with Saikinso Inc. (Headquarters: Shibuya-ku, Tokyo; President: Yu Sawai; hereinafter “Saikinso”), which provides gut flora testing, to expand the gut health market. The two companies began collaborating on the analysis of AuB's gut flora test “BENTRE” in May 2025 and will now implement updates including data integration and the renewal of evaluation metrics. Concurrently, they announce the new name for the test kit: “GUT PARTNER.” The name transition will begin on Wednesday, October 22. Through a revamped test report and support system, they will strengthen their ongoing support aimed at achieving a healthier gut environment.
Functional food with skin elasticity claims using ethyl α-D-glucoside (α-EG) as the functional ingredient has been notified.
Our company has newly demonstrated that ingesting “α-EG,” a component found in Japanese sake, helps maintain the elasticity of the hands and skin in individuals experiencing age-related loss of skin elasticity. We have submitted a notification for a functional food with “α-EG” as a new functional ingredient, which was made public on October 15, 2025. Our Research Institute has long demonstrated that α-EG promotes cell proliferation and collagen production in human skin fibroblasts, and improves skin hydration and rough skin when applied topically. This time, we created a systematic review (SR) based on human oral consumption trial data conducted by an external institution and submitted the notification.
Development of Ultra-High-Concentration Collagen Bioink — High-Definition Reproduction of Complex Shapes via 3D Bioprinting
Nippi Corporation has developed a new ink for 3D bioprinting that enables high-definition modeling while maintaining high collagen concentration. Conventional collagen inks faced limitations in achieving high concentrations because increasing concentration raised viscosity, making dissolution itself difficult. Furthermore, use required gelation treatment through heating and pH adjustment, making operation cumbersome. The resulting structures also had low strength, posing challenges in shape retention and resolution. This new technology represents a step toward overcoming these constraints. The company has previously worked on cartilage regeneration using collagen blocks and bone regeneration using sheet-like materials. However, recognizing the need for shape reproduction tailored to specific cases like bone defects, it turned its attention to 3D bioprinting as a method capable of handling more complex three-dimensional structures. Its simple manufacturing process—kneading fine collagen powder based on patented short-fiber technology with a neutral solvent—eliminates complex steps like cooling, heating, and pH adjustment. This enables easy high-concentration formulation, achieving high-resolution printing with excellent shape retention. Furthermore, in experiments using mesenchymal stem cells (MSCs), a lattice structure was printed using ink prepared at a 15% concentration mixed with a cell suspension, resulting in ink with approximately 10% cell content. This structure maintained its shape and cell viability for about one month. Additionally, the ability to induce differentiation into osteoblasts was confirmed. Applications in the medical and drug discovery fields are anticipated, with potential uses including regenerative medical materials for orthopedics and oral surgery, three-dimensional tissue models, and drug delivery carriers. Nippi will proceed with biocompatibility evaluations and efficacy testing, aiming for practical application as a new material combining “high concentration × high resolution × operability.”
Confirmed effects of fish peptide intake on improving dogs' appetite and coat condition while reducing stress
Suzuhiro Kamaboko Co., Ltd. (Odawara City, Kanagawa Prefecture; President: Tomohiro Suzuki; hereinafter “Suzuhiro”) conducted research on the health support effects of fish peptide intake for pets, with the cooperation of “Peace Wanko Japan” operated by the Specified Nonprofit Corporation Peace Winds Japan (Kamiishi Kogen Town, Hiroshima Prefecture; Representative Director: Kensho Onishi). The study confirmed that fish peptide intake improves dogs' appetite and coat condition while reducing stress. These findings were presented at the “2025 Autumn Meeting of the Japan Society of Fisheries Science” held September 24-26, 2025. (Presentation Title: “Improvement in Appetite and Coat Appearance, and Reduction in Coat Cortisol Content in Dogs Fed Fish-Derived Protein Sources”)
Hypothesis launches first skin care brand to earn MyMicrobiome’s new eczema certification
MyMicrobiome has awarded its new Microbiome-Friendly Eczema certification to Hypothesis, a breakthrough skincare brand from Topaz Biosciences that addresses eczema with first-of-its-kind precision enzyme technology
Byome Labs raises EUR 3.6 million to measure the skin microbiome in stores
The French deeptech startup, founded at the end of 2023, aims to revolutionize cosmetic personalization thanks to the world’s first instant point-of-sale skin microbiome measurement solution. To this end, the company specializing in in vitro skin microbiome analysis, has secured EUR 3.6 million in funding. The round—led by Remora Biotech, Paris Business Angels, Angels Santé, and several strategic business angels—will support the industrialization of Byome Derma, a simple, ultra-fast skin test that can be performed at the point of sale to recommend personalized skincare products based on each individual’s unique microbiome.
Somnee Launches Next-Gen AI-Powered Smart Sleep Headband for Faster Sleep, Deeper Recovery, and Optimized Sleep Performance
Somnee, the award-winning sleep technology delivering pioneering AI-powered neurotech and software that improves sleep, today launched the highly anticipated second-generation smart sleep headband and revamped service, designed for deeper, faster sleep and optimized performance. Launched in 2022 by renowned sleep expert, Dr. Matt Walker, PhD, and an esteemed group of scientists from the University of California, Berkeley, Somnee is a closed-loop sleep aid that tracks your sleep with lab-grade sensors and uses gentle neurostimulation to help you fall asleep faster and maintain deeper, more restorative sleep. Somnee offers a first-of-its-kind, targeted solution for the nearly one in three adults who suffer from poor sleep.
Joint Research on the Cleansing Mechanism of Skin Microbiome Biofilms: Potential for Developing New Phospholipid-Based Skincare Products
L'Oréal Research & Innovation Japan (Research Institute: Kawasaki City, Kanagawa Prefecture; Director: Amit Jayaswal; hereinafter R&I Japan), the Japanese R&D division of the world's largest cosmetics company L'Oréal Group, conducted joint research with Nikko Chemicals Co., Ltd. (Headquarters: Chuo-ku, Tokyo; Representative Director, President and CEO: Hideyuki Nakahara; hereinafter referred to as Nikko Chemicals) on the cleansing mechanism of skin microbiota biofilms. The research findings were presented at the 63rd Annual Meeting of the Society of Oil Chemists of Japan held at Shinshu University from September 3 to 5, 2025, and at the 76th Colloid and Interface Chemistry Symposium held at Chiba University from September 22 to 25, 2025.
ストレスホルモンを連続的に測定できる新しいウェアラブルバイオセンサー「Stressomic」
A new wearable biosensor called “Stressomic” has been developed that can continuously measure stress hormones. This sensor operates by adhering closely to the skin, enabling accurate real-time measurement of fluctuations in cortisol, epinephrine, and norepinephrine in response to stress reactions. This technology can distinguish between acute and chronic stress, and is expected to have significant applications in healthcare and personal health management.Researchers state this sensor enables use across diverse fields, including stress management and exercise guidance.
Deepscent AI Submitted to CES 2026 Innovation Awards in Four Categories
Deepscent Inc., a South Korean IT company specializing in digital olfactory solutions, announced that its Deepscent AI platform has been submitted to the CES 2026 Innovation Awards in four categories: Home Appliances, Smart Home, Smart Communities, and Content & Entertainment.
Indoor greening technology using native plants - Creating indoor spaces where you can experience the changing seasons -
Our company has selected approximately 60 native plant species suitable for indoor cultivation through two years of indoor growth tests, focusing on species that naturally grow in regions with minimal annual temperature fluctuations, such as Okinawa in the southern part of Japan, and those found near our technical center. Additionally, by minimizing the exposed parts of stainless steel planters used for planting, we have developed an indoor greening technology called “T-Biophilic Green,” which replicates the natural form of outdoor environments and allows users to experience the changing seasons indoors.By applying this technology in a growth experiment (5 m²) conducted in the entrance hall of the technical center, the 61 species and 200 plants planted in February 2022 have maintained good growth rates and vegetation coverage as of August 2024. (See Figure 1)
Scentian Bio deploys AI-powered biosensor tech in trial with world’s largest kiwifruit marketer
Scentian Bio—a startup making biosensors utilizing insect olfactory receptors—is using its tech to help the world’s largest kiwifruit marketer determine the optimal time to harvest its fruit. The pilot project is backed by the Zespri Innovation Fund (ZAG), a $2 million fund deployed annually to support trials with companies, social enterprises, or academic institutions with ideas or tech that could help Zespri drive innovation and climate resilience in its operations. Spun out from The New Zealand Institute for Plant and Food Research in 2021, Auckland-based Scentian Bio deploys patented technology developed by founder and CTO Dr. Andrew Králíček to make biosensors that utilize the biological machinery that enable bugs to make sense of their environment through smell.
British Startup Multus Taps AI & Automation to Create Serum-Free Media for Cultivated Meat
UK firm Multus Biotechnology has unveiled an animal-free media formulation for cultivated meat, allowing companies to eliminate serum from their products. To ease ethical concerns, optimise production and lower costs, British company Multus Biotechnology has developed an animal-free culture medium to replace fetal bovine serum (FBS) for cultivated meat. Animal serum contains high amounts of protein, alongside growth factors, hormones, antioxidants, lipids, and other components that replicate a fetal-like state for cell proliferation. It has been used as a key component in cell culture for decades. The problem? It can contain unknown amounts of thousands of different components and poses the threat of antibacterial contamination. It’s also in short supply and thus highly expensive, and has sparked ethical concerns about the use of fetal animals to produce cultivated meat. Over the years, many companies have moved away from cultivated meat to use animal-component-free (ACF) media formulations for production. Multus’s latest innovation, developed with the help of artificial intelligence (AI), adds to the list of solutions for producers in this space.
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
DigitalMedical Open Innovation
デジタル・メディカル・オープンイノベーション
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future
of Health Care
OUR TECHNOLOGY HELPS
YOUR BUSINESS
Our technology will help your business
Technology
Enhancing Gut Health Visualization and Companion Support: Launching Gut Testing Kits in Japan
AuB Inc. (Headquarters: Chuo-ku, Tokyo; President: Keita Suzuki; hereinafter “AuB”), which develops and sells products and services for improving physical condition, has entered into a business partnership agreement with Saikinso Inc. (Headquarters: Shibuya-ku, Tokyo; President: Yu Sawai; hereinafter “Saikinso”), which provides gut flora testing, to expand the gut health market. The two companies began collaborating on the analysis of AuB's gut flora test “BENTRE” in May 2025 and will now implement updates including data integration and the renewal of evaluation metrics. Concurrently, they announce the new name for the test kit: “GUT PARTNER.” The name transition will begin on Wednesday, October 22. Through a revamped test report and support system, they will strengthen their ongoing support aimed at achieving a healthier gut environment.
PR TIMES
Functional food with skin elasticity claims using ethyl α-D-glucoside (α-EG) as the functional ingredient has been notified.
Our company has newly demonstrated that ingesting “α-EG,” a component found in Japanese sake, helps maintain the elasticity of the hands and skin in individuals experiencing age-related loss of skin elasticity. We have submitted a notification for a functional food with “α-EG” as a new functional ingredient, which was made public on October 15, 2025. Our Research Institute has long demonstrated that α-EG promotes cell proliferation and collagen production in human skin fibroblasts, and improves skin hydration and rough skin when applied topically. This time, we created a systematic review (SR) based on human oral consumption trial data conducted by an external institution and submitted the notification.
大関株式会社
Development of Ultra-High-Concentration Collagen Bioink — High-Definition Reproduction of Complex Shapes via 3D Bioprinting
Nippi Corporation has developed a new ink for 3D bioprinting that enables high-definition modeling while maintaining high collagen concentration. Conventional collagen inks faced limitations in achieving high concentrations because increasing concentration raised viscosity, making dissolution itself difficult. Furthermore, use required gelation treatment through heating and pH adjustment, making operation cumbersome. The resulting structures also had low strength, posing challenges in shape retention and resolution. This new technology represents a step toward overcoming these constraints. The company has previously worked on cartilage regeneration using collagen blocks and bone regeneration using sheet-like materials. However, recognizing the need for shape reproduction tailored to specific cases like bone defects, it turned its attention to 3D bioprinting as a method capable of handling more complex three-dimensional structures. Its simple manufacturing process—kneading fine collagen powder based on patented short-fiber technology with a neutral solvent—eliminates complex steps like cooling, heating, and pH adjustment. This enables easy high-concentration formulation, achieving high-resolution printing with excellent shape retention. Furthermore, in experiments using mesenchymal stem cells (MSCs), a lattice structure was printed using ink prepared at a 15% concentration mixed with a cell suspension, resulting in ink with approximately 10% cell content. This structure maintained its shape and cell viability for about one month. Additionally, the ability to induce differentiation into osteoblasts was confirmed. Applications in the medical and drug discovery fields are anticipated, with potential uses including regenerative medical materials for orthopedics and oral surgery, three-dimensional tissue models, and drug delivery carriers. Nippi will proceed with biocompatibility evaluations and efficacy testing, aiming for practical application as a new material combining “high concentration × high resolution × operability.”
DxMedical Cloud™︎
Confirmed effects of fish peptide intake on improving dogs' appetite and coat condition while reducing stress
Suzuhiro Kamaboko Co., Ltd. (Odawara City, Kanagawa Prefecture; President: Tomohiro Suzuki; hereinafter “Suzuhiro”) conducted research on the health support effects of fish peptide intake for pets, with the cooperation of “Peace Wanko Japan” operated by the Specified Nonprofit Corporation Peace Winds Japan (Kamiishi Kogen Town, Hiroshima Prefecture; Representative Director: Kensho Onishi). The study confirmed that fish peptide intake improves dogs' appetite and coat condition while reducing stress. These findings were presented at the “2025 Autumn Meeting of the Japan Society of Fisheries Science” held September 24-26, 2025. (Presentation Title: “Improvement in Appetite and Coat Appearance, and Reduction in Coat Cortisol Content in Dogs Fed Fish-Derived Protein Sources”)
PR TIMES
Hypothesis launches first skin care brand to earn MyMicrobiome’s new eczema certification
MyMicrobiome has awarded its new Microbiome-Friendly Eczema certification to Hypothesis, a breakthrough skincare brand from Topaz Biosciences that addresses eczema with first-of-its-kind precision enzyme technology
Cosmetics Business
Byome Labs raises EUR 3.6 million to measure the skin microbiome in stores
The French deeptech startup, founded at the end of 2023, aims to revolutionize cosmetic personalization thanks to the world’s first instant point-of-sale skin microbiome measurement solution. To this end, the company specializing in in vitro skin microbiome analysis, has secured EUR 3.6 million in funding. The round—led by Remora Biotech, Paris Business Angels, Angels Santé, and several strategic business angels—will support the industrialization of Byome Derma, a simple, ultra-fast skin test that can be performed at the point of sale to recommend personalized skincare products based on each individual’s unique microbiome.
Premium Beauty News
Somnee Launches Next-Gen AI-Powered Smart Sleep Headband for Faster Sleep, Deeper Recovery, and Optimized Sleep Performance
Somnee, the award-winning sleep technology delivering pioneering AI-powered neurotech and software that improves sleep, today launched the highly anticipated second-generation smart sleep headband and revamped service, designed for deeper, faster sleep and optimized performance. Launched in 2022 by renowned sleep expert, Dr. Matt Walker, PhD, and an esteemed group of scientists from the University of California, Berkeley, Somnee is a closed-loop sleep aid that tracks your sleep with lab-grade sensors and uses gentle neurostimulation to help you fall asleep faster and maintain deeper, more restorative sleep. Somnee offers a first-of-its-kind, targeted solution for the nearly one in three adults who suffer from poor sleep.
The AI Journal
Joint Research on the Cleansing Mechanism of Skin Microbiome Biofilms: Potential for Developing New Phospholipid-Based Skincare Products
L'Oréal Research & Innovation Japan (Research Institute: Kawasaki City, Kanagawa Prefecture; Director: Amit Jayaswal; hereinafter R&I Japan), the Japanese R&D division of the world's largest cosmetics company L'Oréal Group, conducted joint research with Nikko Chemicals Co., Ltd. (Headquarters: Chuo-ku, Tokyo; Representative Director, President and CEO: Hideyuki Nakahara; hereinafter referred to as Nikko Chemicals) on the cleansing mechanism of skin microbiota biofilms. The research findings were presented at the 63rd Annual Meeting of the Society of Oil Chemists of Japan held at Shinshu University from September 3 to 5, 2025, and at the 76th Colloid and Interface Chemistry Symposium held at Chiba University from September 22 to 25, 2025.
PR TIMES
ストレスホルモンを連続的に測定できる新しいウェアラブルバイオセンサー「Stressomic」
A new wearable biosensor called “Stressomic” has been developed that can continuously measure stress hormones. This sensor operates by adhering closely to the skin, enabling accurate real-time measurement of fluctuations in cortisol, epinephrine, and norepinephrine in response to stress reactions. This technology can distinguish between acute and chronic stress, and is expected to have significant applications in healthcare and personal health management.Researchers state this sensor enables use across diverse fields, including stress management and exercise guidance.
Inside Precision Medicine
Deepscent AI Submitted to CES 2026 Innovation Awards in Four Categories
Deepscent Inc., a South Korean IT company specializing in digital olfactory solutions, announced that its Deepscent AI platform has been submitted to the CES 2026 Innovation Awards in four categories: Home Appliances, Smart Home, Smart Communities, and Content & Entertainment.
businesswire
Indoor greening technology using native plants - Creating indoor spaces where you can experience the changing seasons -
Our company has selected approximately 60 native plant species suitable for indoor cultivation through two years of indoor growth tests, focusing on species that naturally grow in regions with minimal annual temperature fluctuations, such as Okinawa in the southern part of Japan, and those found near our technical center. Additionally, by minimizing the exposed parts of stainless steel planters used for planting, we have developed an indoor greening technology called “T-Biophilic Green,” which replicates the natural form of outdoor environments and allows users to experience the changing seasons indoors.By applying this technology in a growth experiment (5 m²) conducted in the entrance hall of the technical center, the 61 species and 200 plants planted in February 2022 have maintained good growth rates and vegetation coverage as of August 2024. (See Figure 1)
大成建設
Scentian Bio deploys AI-powered biosensor tech in trial with world’s largest kiwifruit marketer
Scentian Bio—a startup making biosensors utilizing insect olfactory receptors—is using its tech to help the world’s largest kiwifruit marketer determine the optimal time to harvest its fruit. The pilot project is backed by the Zespri Innovation Fund (ZAG), a $2 million fund deployed annually to support trials with companies, social enterprises, or academic institutions with ideas or tech that could help Zespri drive innovation and climate resilience in its operations. Spun out from The New Zealand Institute for Plant and Food Research in 2021, Auckland-based Scentian Bio deploys patented technology developed by founder and CTO Dr. Andrew Králíček to make biosensors that utilize the biological machinery that enable bugs to make sense of their environment through smell.
AFN
British Startup Multus Taps AI & Automation to Create Serum-Free Media for Cultivated Meat
UK firm Multus Biotechnology has unveiled an animal-free media formulation for cultivated meat, allowing companies to eliminate serum from their products. To ease ethical concerns, optimise production and lower costs, British company Multus Biotechnology has developed an animal-free culture medium to replace fetal bovine serum (FBS) for cultivated meat. Animal serum contains high amounts of protein, alongside growth factors, hormones, antioxidants, lipids, and other components that replicate a fetal-like state for cell proliferation. It has been used as a key component in cell culture for decades. The problem? It can contain unknown amounts of thousands of different components and poses the threat of antibacterial contamination. It’s also in short supply and thus highly expensive, and has sparked ethical concerns about the use of fetal animals to produce cultivated meat. Over the years, many companies have moved away from cultivated meat to use animal-component-free (ACF) media formulations for production. Multus’s latest innovation, developed with the help of artificial intelligence (AI), adds to the list of solutions for producers in this space.
green queen